Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/11/2010 | EP2214690A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
08/11/2010 | EP2214689A2 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition |
08/11/2010 | EP2214673A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines |
08/11/2010 | EP1911763B1 Compositions for the treatment of gastrointestinal disorders |
08/11/2010 | EP1531791B1 Prevention and reduction of ischemia |
08/11/2010 | EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients |
08/11/2010 | EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament |
08/11/2010 | EP1135415B1 Humanized antibodies to gamma-interferon |
08/11/2010 | CN201542976U Novel black plaster with acupuncture point therapeutic function |
08/11/2010 | CN1649551B Drug-delivery endovascular stent and method for treating restenosis |
08/11/2010 | CN101802197A Single-chain FC (ScFc) regions, binding polypeptides comprising same, and methods related thereto |
08/11/2010 | CN101801971A Deazapurines useful as inhibitors of janus kinases |
08/11/2010 | CN101801907A Compounds isolated from antrodia cinnamomea and use thereof |
08/11/2010 | CN101801462A Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
08/11/2010 | CN101801377A Anti-inflammatory composition |
08/11/2010 | CN101798558A Ant and ginseng wine |
08/11/2010 | CN101798356A Method for separating and extracting natural tea polysaccharide |
08/11/2010 | CN101798347A Monoclonal antibody for resisting high mobility group protein B1 |
08/11/2010 | CN101798333A Tetraterpene compound and derivatives thereof for treating cancer, inflammation and central nervous system diseases |
08/11/2010 | CN101798285A Sinomenine derivate, synthesis method and application thereof |
08/11/2010 | CN101797372A Fire-friend cold capsule |
08/11/2010 | CN101797360A Fingerprint detection method for analgesic plaster |
08/11/2010 | CN101797354A General prescription for treating dampness and heat (dampness and heat antidote and dampness and heat drying agent) |
08/11/2010 | CN101797349A Plaster for treating traumatic injury and preparation method thereof |
08/11/2010 | CN101797342A Traditional Chinese medicine for treating rheumatoid and chronic infectious arthritis |
08/11/2010 | CN101797336A Granule preparation for treating cold and preparation method thereof |
08/11/2010 | CN101797327A Chinese medicinal preparation for treating pain caused by orthopedic diseases |
08/11/2010 | CN101797325A Medicament composition for treating gynecologic inflammation and preparation method and application thereof |
08/11/2010 | CN101797316A Traditional Chinese medicine for treating hyperpyrexia and infantile convulsion and preparation method thereof |
08/11/2010 | CN101797311A Medicinal composition for treating neck, shoulder, waist and leg pains and application thereof |
08/11/2010 | CN101797306A Traditional Chinese medicine for treating wet pleurisy and preparation method thereof |
08/11/2010 | CN101797278A Tripterygium wilfordii Hook.f total terpenoid vesicles and preparation method thereof |
08/11/2010 | CN101797263A Traditional Chinese medicine composite for antibiosis and antiphlogosis |
08/11/2010 | CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
08/11/2010 | CN101797239A Strychnos alkaloid vesicle and preparation method thereof |
08/11/2010 | CN101797218A Prescription for preparing paracetamol freezable oral liquid |
08/11/2010 | CN101485447B Ferulaic acid cyclodextrin inclusion compound preparation method |
08/11/2010 | CN101485446B Preparation method of garlic oil cyclodextrin or cyclodextrin derivate inclusion compound |
08/11/2010 | CN101293876B Benzoxazole ketones derivative and preparation method thereof |
08/11/2010 | CN101264075B Application of 2', 5, 6', 7-tetrahydroxy dihydroflavonol for treating sepsis |
08/11/2010 | CN101185663B Method for obtaining the extraction from caper medicinal part and application of the extraction |
08/11/2010 | CN101181568B Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache |
08/11/2010 | CN101116683B Medicine for treating arthritis |
08/11/2010 | CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing |
08/10/2010 | USRE41489 Method of providing sustained analgesia with buprenorphine |
08/10/2010 | US7772427 Uses for amino acid anticonvulsants |
08/10/2010 | US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis |
08/10/2010 | US7772249 Imidazo[1,2-b]pyridazine compound |
08/10/2010 | US7772236 Substituted pyrazoles |
08/10/2010 | US7772233 Arylamino N-heteroaryl compounds as MEK inhibitors |
08/10/2010 | US7772232 Quinazolinyl compounds as inhibitors of potassium channel function |
08/10/2010 | US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes |
08/10/2010 | US7771932 based on the determination of the simultaneous presence of the molecular group CD4, CD18 and/or CD11a, CD49b; treating an autoimmune or inflammatory disease; Crohn's disease |
08/10/2010 | US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region |
08/10/2010 | US7771733 Compositions and methods for enhancing corticosteroid delivery |
08/10/2010 | CA2528818C Topical aerosol foams |
08/10/2010 | CA2463227C Steroidal compounds for inhibiting steroid sulphotase |
08/10/2010 | CA2451605C Diamine derivatives |
08/10/2010 | CA2451452C Cyclic diamine compound with condensed-ring groups |
08/10/2010 | CA2447021C Pyridyl cyanoguanidine compounds |
08/10/2010 | CA2444506C Orodispersible effervescent tablets |
08/10/2010 | CA2440714C Pyrazolopyrimidines as therapeutic agents |
08/10/2010 | CA2391832C Oral dosage forms |
08/10/2010 | CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors |
08/10/2010 | CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
08/10/2010 | CA2361617C Uses of thank, a tnf homologue that activates apoptosis |
08/10/2010 | CA2237099C Sulfonylaminocarboxylic acids |
08/05/2010 | WO2010088375A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy |
08/05/2010 | WO2010088050A2 Bicyclic pyrazolo-heterocycles |
08/05/2010 | WO2010087594A9 Cd93 or use of soluble fragment thereof |
08/05/2010 | WO2010087594A2 Cd93 or use of soluble fragment thereof |
08/05/2010 | WO2010087521A1 Combined preparation for treating joint diseases |
08/05/2010 | WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism |
08/05/2010 | WO2010087467A1 Delta-5-desaturase inhibitors |
08/05/2010 | WO2010087244A1 Cyclic amino alcohol compound |
08/05/2010 | WO2010086972A1 Antistress agent |
08/05/2010 | WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
08/05/2010 | WO2010086403A1 Azetidines as histamine h3 receptor antagonists |
08/05/2010 | WO2010086350A1 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases |
08/05/2010 | WO2010086349A1 Anti-inflammatory macrolide |
08/05/2010 | WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
08/05/2010 | WO2010053580A3 Reducing the risk of smoke-related disease |
08/05/2010 | WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
08/05/2010 | WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/05/2010 | US20100197918 2,4-pyrimidinediamine compounds and their uses |
08/05/2010 | US20100197917 Coumarin derivatives useful as tnf alpha inhibitors |
08/05/2010 | US20100197911 Nitrogen-Containing Aromatic Derivatives |
08/05/2010 | US20100197907 Phosphorus-containing compounds & uses thereof |
08/05/2010 | US20100197797 Methods of managing fibromyalgia using milnacipran |
08/05/2010 | US20100197791 Pharmaceuticals for transdermal use on animals |
08/05/2010 | US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
08/05/2010 | US20100197751 Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
08/05/2010 | US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists |
08/05/2010 | US20100197714 Spiro-pyrano-pyrazole derivatives |
08/05/2010 | US20100197711 Benzothiazole compounds |
08/05/2010 | US20100197708 Indole compounds |
08/05/2010 | US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists |
08/05/2010 | US20100197687 Indoles Useful in the Treatment of Inflammation |
08/05/2010 | US20100197684 Substituted heterocyclic compounds |
08/05/2010 | US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors |